Evidence map›Paper›PMID 30026603›Full record

ArticleNature communications2018

FoxM1 repression during human aging leads to mitotic decline and aneuploidy-driven full senescence.

Joana Catarina Macedo, Sara Vaz, Bjorn Bakker, Rui Ribeiro, Petra Lammigje Bakker, Jose Miguel Escandell, Miguel Godinho Ferreira, René Medema, Floris Foijer, Elsa Logarinho

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 1 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 1 synthesis or guideline pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Joana Catarina MacedoAging and Aneuploidy Laboratory, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.
Sara VazAging and Aneuploidy Laboratory, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.
Bjorn BakkerEuropean Research Institute for the Biology of Aging, University of Groningen, University Medical Center Groningen, NL-9713 AV, Groningen, The Netherlands.
Rui RibeiroAging and Aneuploidy Laboratory, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal.ORCID http://orcid.org/0000-0003-3759-2399
Petra Lammigje BakkerEuropean Research Institute for the Biology of Aging, University of Groningen, University Medical Center Groningen, NL-9713 AV, Groningen, The Netherlands.
Jose Miguel EscandellTelomere and Genome Stability Laboratory, Instituto Gulbenkian de Ciência, 2781-901, Oeiras, Portugal.
Miguel Godinho FerreiraTelomere and Genome Stability Laboratory, Instituto Gulbenkian de Ciência, 2781-901, Oeiras, Portugal.ORCID http://orcid.org/0000-0002-8363-7183
René MedemaDivision of Cell Biology and Cancer Genomics Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
Floris FoijerEuropean Research Institute for the Biology of Aging, University of Groningen, University Medical Center Groningen, NL-9713 AV, Groningen, The Netherlands.ORCID http://orcid.org/0000-0003-0989-3127
Elsa LogarinhoAging and Aneuploidy Laboratory, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135, Porto, Portugal. elsa.logarinho@ibmc.up.pt.ORCID http://orcid.org/0000-0002-8741-0744
Universidade do Porto · PTUniversity Medical Center Groningen · NLInstitut de Recherche sur le Cancer et le Vieillissement de Nice · FRInstituto Gulbenkian de Ciência · PTThe Netherlands Cancer Institute · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aneuploidy, an abnormal chromosome number, has been linked to aging and age-associated diseases, but the underlying molecular mechanisms remain unknown. Here we show, through direct live-cell imaging of young, middle-aged, and old-aged primary human dermal fibroblasts, that aneuploidy increases with aging due to general dysfunction of the mitotic machinery. Increased chromosome mis-segregation in elderly mitotic cells correlates with an early senescence-associated secretory phenotype (SASP) and repression of Forkhead box M1 (FoxM1), the transcription factor that drives G2/M gene expression. FoxM1 induction in elderly and Hutchison-Gilford progeria syndrome fibroblasts prevents aneuploidy and, importantly, ameliorates cellular aging phenotypes. Moreover, we show that senescent fibroblasts isolated from elderly donors' cultures are often aneuploid, and that aneuploidy is a key trigger into full senescence phenotypes. Based on this feedback loop between cellular aging and aneuploidy, we propose modulation of mitotic efficiency through FoxM1 as a potential strategy against aging and progeria syndromes.

Indexed as

AneuploidyMitosisAdolescentAdultAgedAged, 80 and overAgingCellular SenescenceChildChild, PreschoolFibroblastsForkhead Box Protein M1G2 Phase Cell Cycle CheckpointsGene Expression Regulation, DevelopmentalHumansInfantForkhead Box Protein M1FOXM1 protein, human

Identifiers

PMID30026603
PMCPMC6053425
OpenAlexW2883525804

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.